Non-specific cellular components (DNA, lipids, and proteins) (ROS/RNS targets)

Non-specific cellular components refer to the collective group of biological macromolecules, including DNA, lipids, and proteins, that are susceptible to oxidative and nitrosative modification by Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS). While low levels of these reactive species are essential for normal physiological signaling, an imbalance—termed oxidative stress—leads to indiscriminate damage such as lipid peroxidation, protein denaturation, and genomic instability (PubMed: 23675073). This broad-spectrum damage is implicated in the pathogenesis of numerous conditions, including cancer, Alzheimer's disease, and atherosclerosis (NIH: PMC2990475). Pharmacological intervention typically follows two divergent paths: the administration of antioxidants to mitigate damage in chronic inflammatory or degenerative states, or the use of pro-oxidant agents like certain chemotherapeutics and radiation to overwhelm the antioxidant defenses of tumor cells, leading to cell death (PubMed: 28249118). Because these targets are ubiquitous and the damage is non-specific, achieving a therapeutic window without disrupting vital redox-regulated processes remains a significant challenge in drug development.

Other names

Oxidative stress targetsReactive oxygen species targetsReactive nitrogen species targetsCellular macromoleculesRedox-sensitive cellular components

Drugs targeting these components typically act by either scavenging ROS/RNS to prevent oxidative damage (antioxidants) or by intentionally increasing the production of these species to induce oxidative stress-mediated apoptosis in target cells, such as in cancer therapy (PubMed: 28249118).